Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
The filing notifies a proposed sale of 12,005 shares of Vital Farms, Inc. common stock, with an aggregate market value of $573,238.75, to be sold on or about 08/15/2025 through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The shares were acquired as Restricted Stock Units on 03/22/2022 from the issuer. The filing reports 44,685,980 shares outstanding for the class and indicates no securities sold in the past three months by the reporting person. No additional remarks, trading plan date, or signatures are provided in the disclosed content.
Vital Farms, Inc. (VITL) Form 4: Director Karl Khoury reported the sale of 20,000 shares of Vital Farms common stock on 08/13/2025 at a weighted average price of $47.63 per share, with prices in the range $47.60 to $47.64. After the sale, Mr. Khoury beneficially owned 114,789 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025 and indicates the filing was submitted by a single reporting person. The filing discloses the weighted-average pricing and offers to provide details of the number of shares sold at each price within the stated range.
Vital Farms, Inc. filed an amended report to update the outcome of its advisory “say-on-frequency” vote from the 2025 annual stockholders meeting. Stockholders indicated a preference for holding the advisory vote on executive compensation every year rather than every two or three years.
In line with that stockholder vote and the Board of Directors’ prior recommendation, Vital Farms has decided to hold future non-binding advisory say-on-pay votes annually. This annual cadence will continue until the next required say-on-frequency vote, which must occur no later than the company’s 2031 annual stockholders meeting.
Russell Diez-Canseco, President, CEO and Director of Vital Farms, Inc. (VITL), reported an open-market sale of 16,700 shares on 08/12/2025 under a Rule 10b5-1 trading plan adopted May 12, 2025. The filing shows a weighted average sale price of $46.11, with individual trade prices ranging from $45.39 to $46.31. After the disposition, the reporting person beneficially owns 702,476 shares directly, which includes 277 shares acquired on May 15, 2025 under the companys Employee Stock Purchase Plan. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Stephanie Coon, SVP Strategy at Vital Farms, Inc. (VITL), reported an insider sale. On 08/12/2025 she disposed of 10,005 shares of Vital Farms common stock in transactions executed at a weighted average price of $46.15 per share. After the sale she beneficially owned 45,779 shares. The filing notes 359 shares included in the post-transaction total were purchased on May 15, 2025 under the company Employee Stock Purchase Plan in an exempt transaction. The Form 4 was signed by an attorney-in-fact on 08/14/2025.
Form 144 notice for Vital Farms, Inc. (VITL): The filer proposes to sell 3,393 shares of Common stock with an aggregate market value of $161,981.82. The shares are scheduled for sale on or about 08/14/2025 on NASDAQ. The securities were acquired as Restricted Stock Units from the issuer on 03/17/2024 and the acquisition/vesting date is recorded as 03/17/2024. The filing also discloses three prior 10b5-1 sales by the same account: 1,200 shares sold on 06/12/2025 for $38,316.00, 1,200 shares sold on 07/11/2025 for $46,764.00, and 1,200 shares sold on 08/11/2025 for $54,672.00. Certain filer identification fields (CIK/Name) and contact details are not provided in the visible content.
Vital Farms, Inc. is the subject of a Form 144 reporting a proposed sale of 6,086 common shares with an aggregate market value of $290,376.64, slated for sale on 08/14/2025 on Nasdaq. The filing shows these securities were acquired on 08/11/2025 as a stock bonus from Vital Farms Inc, where the holder received 18,475 shares and now proposes to sell a portion. The company has 44,685,980 shares outstanding, so the proposed sale represents approximately 0.014% of outstanding shares. The notice states there were no securities sold in the past three months by the reporting person and includes the standard representation that the seller is not aware of any undisclosed material adverse information.
Vital Farms, Inc. filed a Form 144 reporting a proposed sale of 20,000 common shares through J.P. Morgan Securities LLC on Nasdaq with an approximate sale date of 08/13/2025. The filing lists an aggregate market value of $924,200 and shows 44,685,980 shares outstanding.
The securities were acquired on 01/06/2015 in a private transaction from the issuer, with an original acquisition amount of 129,230 shares and payment dated 01/06/2015. The filing reports "Nothing to Report" for securities sold in the past three months. The document includes the standard certification that the filer does not know of any undisclosed material adverse information; certain fields such as the filer relationship to the issuer and the notice date are not specified in the provided text.
Peter Nicholas Pappas, identified as a director and an officer (CSO and President, Eggs) of Vital Farms, Inc. (VITL), reported a sale of common stock on 08/11/2025. The Form 4 shows 2,811 shares sold at $45.35 and reports 65,430 shares beneficially owned by the reporting person after the transaction. The filing also discloses acquisition of 500 shares on May 15, 2025 under the company employee stock purchase plan and corrects a prior one-share understatement in a December 2, 2024 filing. The Form is signed by an attorney-in-fact on behalf of the reporting person.
Wrede Thilo, identified as Chief Financial Officer of Vital Farms, Inc. (VITL), reported a sale of common stock on 08/11/2025. The filing shows 1,200 shares were disposed of at a reported price of $45.56 per share.
After the transaction the reporting person beneficially owned 54,987 shares. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted March 13, 2025. The Form 4 was submitted by one reporting person and lists a C/O Vital Farms Austin address.